Table 3 Clinical outcomes of patients with acute myocardial infarction according to Statin treatment at discharge during 3-year follow-up.
Clinical outcomes | High-statin (n = 521) | Low/Moderate-statin (n = 1419) | No statin (n = 123) | P-value |
|---|---|---|---|---|
Primary endpoint Cardiac death or MI | 60 (11.5) | 177 (12.5) | 27 (22.0) | 0.001 |
Secondary endpoint | ||||
MACE* | 106 (20.3) | 311 (21.9) | 44 (35.8) | 0.001 |
TLF** | 50 (9.6) | 165 (11.6) | 27 (22.0) | 0.001 |
TVF*** | 70 (13.4) | 207 (14.6) | 32 (26.0) | 0.002 |
PFCE**** | 104 (20.0) | 341 (24.0) | 49 (39.8) | < 0.001 |
Total death | 70 (13.4) | 217 (15.2) | 35 (28.4) | < 0.001 |
Cardiac death | 42 (8.0) | 134 (9.4) | 24 (19.5) | < 0.001 |
Non-cardiac death | 28 (5.3) | 83 (5.8) | 11 (8.9) | 0.315 |
Myocardial infarction | 23 (4.4) | 52 (3.6) | 5 (4.0) | 0.745 |
STEMI | 6 (1.1) | 9 (0.6) | 1 (0.8) | 0.515 |
NSTEMI | 17 (3.2) | 43 (3.0) | 4 (3.2) | 0.962 |
Repeat revascularization | 40 (7.6) | 94 (6.6) | 9 (7.3) | 0.710 |
TLR | 8 (1.5) | 32 (2.2) | 3 (2.4) | 0.592 |
TVR | 18 (3.4) | 52 (3.6) | 5 (4.0) | 0.943 |
Non-TVR | 23 (4.4) | 45 (3.1) | 5 (4.0) | 0.400 |
Stroke | 14 (2.6) | 46 (3.2) | 4 (3.2) | 0.819 |
Hemorrhagic | 2 (0.4) | 12 (0.8) | 1 (0.8) | 0.566 |
Ischemic | 9 (1.7) | 34 (2.4) | 3 (2.4) | 0.668 |
Stent thrombosis | 4 (0.7) | 6 (0.4) | 0 (0.0) | 0.455 |
Re-hospitalization | 27 (5.1) | 113 (7.9) | 16 (13.0) | 0.008 |
